Am J Transplant, Volume 18, Suppl 3 Archives - Page 128 of 211 - ATC Abstracts

2018 American Transplant Congress
The Impact of Rapamycin Conversion in Pediatric Liver Transplantation on Anti-HLA Antibody Formation and Allograft Fibrosis
R. Fischer,² L. Fromm,¹ J. Daniel,² A. Kats,² R. Hendrickson,² W. Andrews.²
¹University of Kansas College of Medicine, Kansas City, KS; ²Children's Mercy Hospital, Kansas City, MO.
Background: Maintenance immunosuppression with tacrolimus (TAC) is associated with progressive liver allograft fibrosis. Conversion to rapamycin (RAPA) may abrogate this progression. The development of donor-specific…
2018 American Transplant Congress
Why the Low Usage of HIV Positive Donors? A Survey of the Transplant Community
S. Nazarian,¹ C. Watts,² D. Sawinski,² P. Reese,² D. Goldberg,² P. Abt,¹ S. Halpern,² J. Shea,² E. Blumberg.²
¹Surgery, University of Pennsylvania, Philadelphia, PA; ²Medicine, University of Pennsylvania, Philadelphia, PA.
BackgroundSince the HIV Policy Equity Act of 2013, 22 programs have been approved to use HIV+ kidneys and livers, yet these transplants remain uncommon. It…
2018 American Transplant Congress
Procurement Travel Safety: Current Practices, Accident Frequency, Perceptions of Safety and Means to Reduce Risk
A. Schenk, A. Adams, R. Lynch.
Emory Transplant Center, Emory University, Atlanta, GA.
Transplant procurement teams travel extensively. Though considered hazardous, little data on the necessity and risks of this travel exist. We conducted a survey of ASTS…
2018 American Transplant Congress
Organ Transplant Abuse in China (2): Continued Growth after Gaining International Attention
G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
¹China Organ Harvest Research Center, Middletown, NY; ²MD Anderson Cancer Center, University of Texas, Houston, TX.
PurposeThe government of China has responded to allegations that China has been harvesting organs from prisoners of conscience in extrajudicial killings on a large scale…
2018 American Transplant Congress
Discriminative Accuracy of Physician Assessments of Kidney Transplant Candidate Function by Candidate Age, Sex, and Race
M. Harhay,¹ K. Ranganna,¹ L. Levin Mizrahi,¹ G. Xiao,¹ G. Malat,¹ D. Reich,¹ S. Guy,¹ P. Reese.²
¹Drexel University College of Medicine, Philadelphia, PA; ²Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Background: Clinical assessments of patient health status are integral in kidney transplant (KT) waiting list management. Few data exist on the whether the accuracy of…
2018 American Transplant Congress
Psychosocial Factors Affecting Recipients of Vascular Composite Allotransplantation
S. Rasmussen, M. Henderson, C. Cooney, J. Shores, W. Lee, D. Segev, G. Brandacher.
JHU, Baltimore.
Background: While vascularized composite allotransplantation (VCA) is an increasingly successful therapy, medication non-adherence appears to be an important cause of graft loss. Psychosocial factors predict…
2018 American Transplant Congress
Parathyroid Cell Xenotransplantation with Ultrapure Alginate Based Microencapsulation Technique
B. Goncu,¹ E. Yucesan,² H. Basoglu,³ M. Celikten,¹ O. Huseyinbas,¹ B. Ozdemir,¹ N. Ozten Kandas,⁴ F. Akbas,⁵ Y. Ersoy,⁶ E. Aysan.⁶
¹Bezmialem Vakif University, Experimental Research Center, Istanbul, Turkey; ²Bezmialem Vakif University, Institute of Life Sciences and Biotechnology, Istanbul, Turkey; ³Bezmialem Vakif University, Faculty of Medicine, Department of Biophysics, Istanbul, Turkey; ⁴Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Istanbul, Turkey; ⁵Bezmialem Vakif University, Faculty of Medicine, Department of Medical Biology, Istanbul, Turkey; ⁶Bezmialem Vakif University, Faculty of Medicine, Department of General Surgery, Istanbul, Turkey.
Permanent hypoparathyroidism (PH) is a serious clinical condition and unique treatment option is parathyroid allotransplantation (PA). The most important obstacle for PA is an immune…
2018 American Transplant Congress
NKG2C+CD57+ NK (G2C+57+) Cells Expanded by CMV Infection Are Highly Responsive to Allo-Antibody (Ab)-Mediated NK Cell Stimulation
B. Shin,¹ D. Puliyanda,² H. Pizzo,² S. Jordan,² M. Toyoda.¹
¹Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA; ²Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Introduction: Active CMV infection is known to be associated with risk for ABMR in allograft recipients. Ab-dependent cellular cytotoxicity (ADCC) primarily mediated by NK cells…
2018 American Transplant Congress
Genetic Risk Factors of Post-Transplant Thrombocytopenia in Kidney Allograft Recipients
D. Min,¹ Y. Chang,² T. Shah.³
¹College of Pharmacy, Western University of Health Sciences, Pomoma, CA; ²National Institute of Transplantation Foundation, Los Angeles, CA; ³Multiorgan Transplantation Center, St. Vincent Medical Center, Los Angeles, CA.
Background: Posttransplant thrombocytopenia is prevalent after renal transplantation, which is associated with increased risk of bleeding and other complications. The CXC motif chemokine 12 (CXCL12)…
2018 American Transplant Congress
Kidney Transplantation (KTx) Using Kidneys from Deceased Donors (DD) with Severe AKI Does Not Negatively Impact 1 Year Biopsy Chronic Changes
A. Kumar, A. Srinivasan, A. Mathur, J. Huskey, H. Khamash, M. Smith, A. Moss, K. Reddy, R. Heilman.
Mayo Clinic, Phoenix.
BackgroundDespite the persistent donor shortage, donor kidneys with an acute kidney injury are declined. The aim of this study to determine the difference in biopsy…